Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  312 results for ""DRUG monitoring""

Your Filters

Publisher : bmj publishing group Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand.

  • Authors : Larcombe R; University of South Australia, Adelaide, South Australia, Australia .; Flinders Medical Centre, Bedford Park, South Australia, Australia.

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy ; Tobramycin*/Tobramycin*/Tobramycin*/administration & dosage ; Tobramycin*/Tobramycin*/Tobramycin*/blood

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Jun 21; Vol. 31 (4), pp. 301-306. Date of Electronic Publication: 2024 Jun 21.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of pharmacokinetics software for therapeutic drug monitoring of piperacillin in patients with severe infections.

Subjects: Drug Monitoring*/Drug Monitoring*/Drug Monitoring*/methods ; Piperacillin*/Piperacillin*/Piperacillin*/pharmacokinetics ; Piperacillin*/Piperacillin*/Piperacillin*/blood

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Apr 23; Vol. 31 (3), pp. 201-206. Date of Electronic Publication: 2024 Apr 23.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical benefits of therapeutic drug monitoring of vancomycin therapy in patients with postoperative intracerebral hemorrhage: a retrospective cohort study.

  • Authors : Liu H; Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot, Inner Mongolia, China.; Department of Pharmacy, Baotou Medical College, Baotou, Inner Mongolia, China.

Subjects: Drug Monitoring*/Drug Monitoring*/Drug Monitoring*/methods ; Vancomycin*/Vancomycin*/Vancomycin*/blood ; Vancomycin*/Vancomycin*/Vancomycin*/administration & dosage

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Apr 23; Vol. 31 (3), pp. 240-246. Date of Electronic Publication: 2024 Apr 23.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Meropenem population pharmacokinetics and model-based dosing optimisation in patients with serious bacterial infection.

  • Authors : Murínová I; Department of Clinical Pharmacy, Military University Hospital Prague, Prague, Czech Republic.; Department of Applied Pharmacy, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic.

Subjects: Meropenem*/Meropenem*/Meropenem*/pharmacokinetics ; Meropenem*/Meropenem*/Meropenem*/administration & dosage ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/pharmacokinetics

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Apr 23; Vol. 31 (3), pp. 253-258. Date of Electronic Publication: 2024 Apr 23.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).

  • Authors : Koch M; Clinical Neurosciences, University of Calgary, Calgary, AB T2N 1N4, Canada .

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/drug therapy; Humans

  • Source: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 Apr 12; Vol. 95 (5), pp. 391. Date of Electronic Publication: 2024 Apr 12.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).

  • Authors : Toorop AA; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands .; van Lierop ZY

Subjects: Leukoencephalopathy, Progressive Multifocal*/Leukoencephalopathy, Progressive Multifocal*/Leukoencephalopathy, Progressive Multifocal*/etiology ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/Multiple Sclerosis, Relapsing-Remitting*/drug therapy

  • Source: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 Apr 12; Vol. 95 (5), pp. 392-400. Date of Electronic Publication: 2024 Apr 12.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Levetiracetam pharmacokinetics and its covariates: proposal for optimal dosing in the paediatric population.

  • Authors : Pokorná P; Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.; Department of Physiology and Pharmacology, Karolinska University Hospital, Stockholm, Sweden.

Subjects: Anticonvulsants* ; Valproic Acid*; Child

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2023 Nov; Vol. 30 (6), pp. 359-362. Date of Electronic Publication: 2021 Nov 09.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Therapeutic drug monitoring of linezolid: HPLC-based assays for routine quantification of linezolid in human serum and cerebrospinal fluid.

  • Authors : Günther S; The Department of Anaesthesiology & Intensive Care, Philipps-Universitat Marburg, Marburg, Hessen, Germany .; the Department of Pharmacy, Regionale Kliniken Holding RKH GmbH, Ludwigsburg, Baden-Württemberg, Germany.

Subjects: Oxazolidinones*; Humans ; Linezolid

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2023 Nov; Vol. 30 (6), pp. 353-358. Date of Electronic Publication: 2022 Jan 06.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists.

  • Authors : Xu L; Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Cheng X

Subjects: Amikacin*/Amikacin*/Amikacin*/chemistry ; Drug Monitoring*/Drug Monitoring*/Drug Monitoring*/methods; Aged

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2022 Mar; Vol. 29 (e1), pp. e77-e82. Date of Electronic Publication: 2021 Nov 17.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study.

  • Authors : Oncu S; Department of Medical Pharmacology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey .; Baskurt A

Subjects: Digoxin*/Digoxin*/Digoxin*/adverse effects ; Drug Monitoring*; Aged

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2021 Nov; Vol. 28 (6), pp. 320-324. Date of Electronic Publication: 2019 Oct 17.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  312 results for ""DRUG monitoring""